Additive endocrine therapy for advanced breast cancer - back to the future (Q37622884)

21 August 2017

1 reference

title

Additive endocrine therapy for advanced breast cancer - back to the future (English)

1 reference

21 August 2017

1 reference

1

Per Eystein Lønning

1 reference

21 August 2017

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

48

1 reference

21 August 2017

8

1 reference

21 August 2017

1092-1101

1 reference

Response to third-line endocrine treatment for advanced breast cancer

21 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Progestins in breast cancer treatment. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Endocrine treatment of breast cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Mechanisms of action of endocrine treatment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

New endocrine drugs for treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Breast cancer: from estrogen to androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

A dose response evaluation of delta-1-testololactone in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Diethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Mechanisms of resistance to aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Aromatase inhibitors: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Suppression of residual oestrogen production with aminoglutethimide in women following surgical hypophysectomy or adrenalectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

Influence of Certain Polycyclic Hydrocarbons on the Growth of the Jensen Rat Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841860903117816

10.3109/02841860903117816

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19863216